M.C. Rouan

Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia.

Renzo Galanello, Antonio Piga, Daniele Alberti et al. · PubMed · 2003 · 171 citations

Medicine, Pharmacokinetics, Pharmacology +17

Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron‐Chelating Agent in Patients with Transfusion‐Dependent Iron Overload Due to β‐Thalassemia

Renzo Galanello, Antonio Piga, Daniele Alberti et al. · The Journal of Clinical Pharmacology · 2003 · 131 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics and Pharmacodynamics of TMC207 and Its <i>N</i> -Desmethyl Metabolite in a Murine Model of Tuberculosis

M.C. Rouan, Nacer Lounis, Tom Gevers et al. · Antimicrobial Agents and Chemotherapy · 2011 · 113 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography

J. B. Lecaillon, M.C. Rouan, C. Souppart et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1982 · 92 citations

Pharmacy, Pharmacokinetics, Pharmacology +6

The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites

M.C. Rouan, J.B. Lecaillon, J. Godbillon et al. · European Journal of Clinical Pharmacology · 1994 · 84 citations

Pharmacy, Pharmacokinetics, Pharmacology +12